Prime Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 6.00 M
as on 17-11-2024
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 57.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 17.35 Cr
as on 17-11-2024
- Revenue 29.69%
(FY 2023)
- Profit 112.35%
(FY 2023)
- Ebitda 80.86%
(FY 2023)
- Net Worth 54.50%
(FY 2023)
- Total Assets 39.59%
(FY 2023)
About Prime Pharmaceuticals
The Corporate was formerly known as Prime Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹57.00 Cr. The company has closed loans amounting to ₹17.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramamurthy Ayyavuthevar, Devang Thakar, Ashish Vora, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231MH1995PTC092543
- Company No.
092543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Prime Pharmaceuticals Private Limited offer?
Prime Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutraceuticals, Pharmaceutical Medicine, Pharmaceutical Products, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Prime Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Vora  | Director | 31-May-2024 | Current |
| Ramamurthy Ayyavuthevar | Director | 05-Feb-2021 | Current |
| Devang Thakar | Director | 02-Apr-1998 | Current |
| Ashish Vora | Director | 11-Sep-1995 | Current |
| Manish Patel | Director | 02-Apr-1998 | Current |
| Irfan Vazirally | Director | 20-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Prime Pharmaceuticals.
Prime Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.69% increase. The company also saw a substantial improvement in profitability, with a 112.35% increase in profit. The company's net worth Soared by an impressive increase of 54.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Pharmaceuticals?
In 2023, Prime Pharmaceuticals had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regenix Super Speciality Laboratories Private LimitedActive 13 years 6 monthsRamamurthy Ayyavuthevar is a mutual person
Regenix Biosciences LimitedActive 18 years 9 monthsRamamurthy Ayyavuthevar and Ashish Vora are mutual person
Odon Prime Pharma Private LimitedActive 7 months 12 daysAshish Vora and Manish Vora are mutual person
- Pharmacheck Consulting Services Private LimitedActive 8 years 11 months
Irfan Vazirally is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 18 May 2023 | ₹57.00 Cr | Open |
Others Creation Date: 17 Jul 2021 | ₹5.00 M | Satisfied |
Others Creation Date: 25 May 2021 | ₹7.50 M | Satisfied |
How Many Employees Work at Prime Pharmaceuticals?
Prime Pharmaceuticals has a workforce of 6 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prime Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
